Literature DB >> 23150179

TROP2 expression and its evolving role in tumor pathogenesis in systemic tumors.

Shailendra Kapoor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23150179     DOI： 10.1007/s13277-012-0586-x

Source DB:  PubMed          Journal:  Tumour Biol        ISSN： 1010-4283


× No keyword cloud information.
  10 in total

1.  [Expression of TROP2 mRNA in left-sided and right-sided colon cancer and its clinical significance].

Authors:  Kai-Yu Xu; Jin Gu
Journal:  Zhonghua Wei Chang Wai Ke Za Zhi       Date:  2009-05

2.  Expression of the GA733 gene family and its relationship to prognosis in pulmonary adenocarcinoma.

Authors:  Hiromi Kobayashi; Yuko Minami; Yoichi Anami; Yuzuru Kondou; Tatsuo Iijima; Junko Kano; Yukio Morishita; Koji Tsuta; Shinichiro Hayashi; Masayuki Noguchi
Journal:  Virchows Arch       Date:  2010-05-16       Impact factor: 4.064

3.  Different effects of ERβ and TROP2 expression in Chinese patients with early-stage colon cancer.

Authors:  Yu-Jing Fang; Guo-Qiang Wang; Zhen-Hai Lu; Lin Zhang; Ji-Bin Li; Xiao-Jun Wu; Pei-Rong Ding; Qing-Jian Ou; Mei-Fang Zhang; Wu Jiang; Zhi-Zhong Pan; De-Sen Wan
Journal:  Tumour Biol       Date:  2012-09-29

4.  Clinical significance of TROP2 expression in colorectal cancer.

Authors:  Takahiro Ohmachi; Fumiaki Tanaka; Koshi Mimori; Hiroshi Inoue; Katsuhiko Yanaga; Masaki Mori
Journal:  Clin Cancer Res       Date:  2006-05-15       Impact factor: 12.531

5.  Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer.

Authors:  Y J Fang; Z H Lu; G Q Wang; Z Z Pan; Z W Zhou; J P Yun; M F Zhang; D S Wan
Journal:  Int J Colorectal Dis       Date:  2009-05-07       Impact factor: 2.571

6.  TROP2 is epigenetically inactivated and modulates IGF-1R signalling in lung adenocarcinoma.

Authors:  Jau-Chen Lin; Yi-Ying Wu; Jing-Yi Wu; Tzu-Chieh Lin; Chen-Tu Wu; Yih-Leong Chang; Yuh-Shan Jou; Tse-Ming Hong; Pan-Chyr Yang
Journal:  EMBO Mol Med       Date:  2012-03-15       Impact factor: 12.137

7.  Trop2 expression contributes to tumor pathogenesis by activating the ERK MAPK pathway.

Authors:  Rafael Cubas; Sheng Zhang; Min Li; Changyi Chen; Qizhi Yao
Journal:  Mol Cancer       Date:  2010-09-21       Impact factor: 27.401

8.  Significance of EpCAM and TROP2 expression in non-small cell lung cancer.

Authors:  Min Gyoung Pak; Dong Hoon Shin; Chang Hun Lee; Min Ki Lee
Journal:  World J Surg Oncol       Date:  2012-04-06       Impact factor: 2.754

9.  TROP2 expression as prognostic marker for gastric carcinoma.

Authors:  G Mühlmann; G Spizzo; J Gostner; M Zitt; H Maier; P Moser; G Gastl; M Zitt; H M Müller; R Margreiter; D Ofner; D Fong
Journal:  J Clin Pathol       Date:  2008-10-17       Impact factor: 3.411

10.  High expression of TROP2 correlates with poor prognosis in pancreatic cancer.

Authors:  D Fong; P Moser; C Krammel; J M Gostner; R Margreiter; M Mitterer; G Gastl; G Spizzo
Journal:  Br J Cancer       Date:  2008-09-23       Impact factor: 7.640
  10 in total
  2 in total

1.  Trop2 inhibition suppresses the proliferation and invasion of laryngeal carcinoma cells via the extracellular signal-regulated kinase/mitogen-activated protein kinase pathway.

Authors:  Xu-Dong Wang; Qiang Wang; Xiao-Lin Chen; Jian-Fei Huang; Yong Yin; Peng Da; Hao Wu
Journal:  Mol Med Rep       Date:  2015-03-13       Impact factor: 2.952

Review 2.  Cyclooxygenase 2-Regulated Genes an Alternative Avenue to the Development of New Therapeutic Drugs for Colorectal Cancer.

Authors:  Alicia M Hidalgo-Estévez; Konstantinos Stamatakis; Marta Jiménez-Martínez; Ricardo López-Pérez; Manuel Fresno
Journal:  Front Pharmacol       Date:  2020-04-29       Impact factor: 5.810
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.